|
NCSTN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.735040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.299600E-01 |
| Normal-vs-Stage2 |
9.426400E-01 |
| Normal-vs-Stage3 |
3.725800E-01 |
| Normal-vs-Stage4 |
3.821700E-03 |
| Stage1-vs-Stage2 |
3.093000E-01 |
| Stage1-vs-Stage3 |
7.626800E-01 |
| Stage1-vs-Stage4 |
1.212390E-02 |
| Stage2-vs-Stage3 |
4.744400E-01 |
| Stage2-vs-Stage4 |
1.361740E-02 |
| Stage3-vs-Stage4 |
1.555860E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.895900E-02 |
| Normal-vs-AfricanAmerican |
4.241900E-02 |
| Normal-vs-Asian |
7.990100E-02 |
| Caucasian-vs-AfricanAmerican |
3.184400E-01 |
| Caucasian-vs-Asian |
5.553800E-01 |
| AfricanAmerican-vs-Asian |
6.504600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.503160E-01 |
| Normal-vs-Female |
1.861950E-01 |
| Male-vs-Female |
7.662200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.471600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.736190E-01 |
| Normal-vs-Age(61-80Yrs) |
1.476770E-01 |
| Normal-vs-Age(81-100Yrs) |
6.538800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.553600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.842200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.789400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.163200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.297600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.852600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.405000E-01 |
| Classical-VS-Follicular |
2.25850005364236E-09 |
| Classical-VS-Other |
2.110400E-01 |
| Classical-VS-Normal |
5.724600E-03 |
| Tall-VS-Follicular |
1.421960E-02 |
| Tall-VS-Other |
4.988600E-01 |
| Tall-VS-Normal |
3.316400E-01 |
| Follicular-VS-Other |
4.726600E-01 |
| Follicular-VS-Normal |
7.108000E-02 |
| Other-VS-Normal |
9.074400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.089600E-01 |
| Normal-vs-N1 |
1.056830E-01 |
| N0-vs-N1 |
8.103900E-02 |
|
|
